ArticleDiscover oncology2026

MiR-641 targets TMEFF2/MEK/PI3K to promote stem cell characteristics of pancreatic cancer cells.

Hongchao Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.